Page 19 - Glass Machinery Plants & Accessories no. 6/2017

businessnews

www .g lassonline.com

SCHOTT

EXPANSION AT

US MANUFACTURING

PLANT

hot forming technology
creates a chemically
homogeneous inner
Pharmaceutical surface for the vial,
and speciality glass improving its chemical
manufacturer Schott has stability.
invested in the expansion Each batch of vials
of its delamination undergoes a clear control
controlled vials strategy based on the
manufacturing facility in company’s Quicktest,
the US. which uses a predefined
The rise in biotech drug quantitative limit value to
formulations has triggered verify that the delamination
an increasing demand for risk has been reduced and
primary packaging with is under control.
superior surfaces and Optimised manufacturing
high cosmetic quality,” is also the key to
said Christopher Cassidy preventing chips and
VP Sales & Marketing, cracks in the glass surface
North America, Schott and improving overall
Pharmaceutical Packaging. cosmetic quality. This
To cater this need, the facilitates automated
international technology machine inspection
group will be expanding during filling operations
its Schott Vials DC and makes the vials less
(Delamination Controlled) susceptible to breakage.
manufacturing capability “Glass has a remarkably
in the beginning of the first high internal strength”,
quarter of 2018 to also said Cassidy. “Its weak
supply customers from its points are small cracks
Lebanon, PA facility. on the surface or edges.
Over the past few years, Micro-defects caused
delamination has led during production or
to recalls of numerous handling spread inward
injectable drugs. Schott as mechanical stress
said its Vials DC increases.
reduce the risk of glass “This can lead to fractures.
delamination and brings it An intact surface will
under control. already make a glass
It has developed a hot vial twice as resistant to
forming technology to breakage without any
prevent delamination. The additional treatment.”